This Anti-Aging Drug is Disrupting a $600 Billion Industry
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
More Videos
Meta's Superintelligence Labs Unveiled: Analyzing the Tech Giant's Next Bold Move
CFRA’s Angelo Zino joins us to unpack Meta’s Superintelligence Labs and what it means for the future of AI, innovation, and the company’s bold new direction.
AIRO Group Charts a Bold Course Toward the Future of Aerospace and Urban Air Mobility
AIRO CEO Joe Burns and Executive Chairman Chirinjeev Kathuria talks the future of aerospace, drones, and urban air mobility through innovation and synergy.
Go Fund Yourself: From Big Dreams to Big Smiles
RaceForKids.com helps kids thrive against the odds. Dimples LLC is celebrating confidence with National Dimples Day.
Go Fund Yourself: Innovation That Supports Both Land and Life
M8 Systems is transforming agriculture and public spaces. Billibind is helping new moms feel confident and supported.
What to Expect This Summer: Tariffs, Jobs, and Interest Rates
Rob Sockin, Senior Global Economist at Citi, joins J.D. Durkin to discuss tariffs, Q1 review, jobs data, and Fed rate cut expectations.
Swift Strategy: Ten Power Moves from Taylor Every Business (and Person) Can Learn From
Sinéad O’Sullivan explores ten strategic lessons from Taylor Swift’s empire in her new book Good Ideas and Power Moves—dropping September 9, 2025.
